BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2830860)

  • 41. Properties of natural porcine interferons.
    Piasecki E
    J Interferon Res; 1988 Feb; 8(1):61-73. PubMed ID: 2452850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
    Higashihara J; Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiviral and antigenic properties of recombinant porcine interferon gamma.
    Charley B; McCullough K; Martinod S
    Vet Immunol Immunopathol; 1988 Sep; 19(2):95-103. PubMed ID: 2847405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells.
    Samuel CE; Knutson GS
    Virology; 1983 Oct; 130(2):474-84. PubMed ID: 6316641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparisons of dose-response data for various standard and recombinant DNA-derived human interferons.
    Stebbing N; May L
    J Virol Methods; 1982 Dec; 5(5-6):309-15. PubMed ID: 6298267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons.
    Kumar R; Tiwari RK; Kusari J; Sen GC
    J Virol; 1987 Sep; 61(9):2727-32. PubMed ID: 2441075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of antiviral activity induced by interferons alpha, beta, and gamma.
    Vogel SN; Friedman RM; Hogan MM
    Curr Protoc Immunol; 2001 May; Chapter 6():Unit 6.9. PubMed ID: 18432822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type I and Type II interferon receptors.
    Orchansky P; Novick D; Fischer DG; Rubinstein M
    J Interferon Res; 1984; 4(2):275-82. PubMed ID: 6086780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).
    Zheng B; He ML; Wong KL; Lum CT; Poon LL; Peng Y; Guan Y; Lin MC; Kung HF
    J Interferon Cytokine Res; 2004 Jul; 24(7):388-90. PubMed ID: 15296649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
    Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
    J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
    Sim IS; Cerruti RL
    Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentiation of antiproliferative activity by mixtures of human recombinant IFN-alpha 2 and -gamma on growth of human cancer nodules maintained in continuous organotypic culture.
    Martyre MC; Beaupain R; Falcoff E
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):917-22. PubMed ID: 3117562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bovine type II interferon: activity in heterologous cells.
    Babiuk LA; Rouse BT
    Intervirology; 1977; 8(4):250-6. PubMed ID: 194868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of alpha, beta, gamma human interferons and Aspergillus terreus mycotoxins on cell proliferation.
    Pugliese A; Vidotto V; Parisi L; Vitale M; Schioppacassi G; Ceruti M; Tovo PA
    Boll Ist Sieroter Milan; 1986; 65(6):530-7. PubMed ID: 2437939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production and characterization of interferon from endothelial cells.
    Einhorn S; Eldor A; Vlodavsky I; Fuks Z; Panet A
    J Cell Physiol; 1985 Feb; 122(2):200-4. PubMed ID: 2578473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta.
    Vancová I; La Bonnardiere C; Kontsek P
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1647-9. PubMed ID: 9680126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new assay system for guinea pig interferon biological activity.
    Yamamoto T; Jeevan A; Ohishi K; Nojima Y; Umemori K; Yamamoto S; McMurray DN
    J Interferon Cytokine Res; 2002 Jul; 22(7):793-7. PubMed ID: 12184917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential antiproliferative effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines.
    Brunda MJ; Wright RB
    Int J Cancer; 1986 Feb; 37(2):287-91. PubMed ID: 3080378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.
    Yamamoto JK; Barré-Sinoussi F; Bolton V; Pedersen NC; Gardner MB
    J Interferon Res; 1986 Apr; 6(2):143-52. PubMed ID: 2425014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.